Oncological and functional outcomes of focal irreversible electroporation for localised prostate cancer: a single institution series of 171 cases

Genitourinary Cancer

Long-term oncological outcomes from a prospective cohort of patients with localised prostate cancer

BJU Int

Baskin AS, Hoffman KE, Penson DF, Huang LC, Zhao Z, Awamlh BAHA, Joyce DD, Morgans AK, Tosoian JJ, Wallis CJD, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, O'Neil BB, Koyama T, Barocas DA

doi: 10.1111/bju.70410

Genitourinary Cancer

Oncological Outcomes Following Focal HIFU and Cryotherapy for Treatment of Nonmetastatic Prostate Cancer in the United Kingdom: An Updated Analysis of 3477 Patients from the Prospective HEAT and ICE Registries

Eur Urol

Light A, Peters M, Gopalakrishnan A, Mayor N, Cullen E, Boaz RJ, Norris JM, Morris S, Arya M, Tanaka MB, Doherty A, Dudderidge T, Emara A, Emberton M, Grey A, Hindley R, Laniado M, McCraken S, Moore CM, Nigam R, Noureldin M, Orczyk C, Rakauskas A, Simmons L, Virdi J, Withington J, Zakikhani P, Ahmed HU, Shah TT

doi: 10.1016/j.eururo.2026.05.007

Genitourinary Cancer

Focal radiation therapies for localized prostate cancer: a systematic review of clinical evidence and outcomes

Prostate Cancer Prostatic Dis

Le Guévelou J, Peyrottes A, Barret E, Ploussard G, Dariane C, Anract J, Olivier J, Chargari C, Zilli T

doi: 10.1038/s41391-025-01050-y

Genitourinary Cancer

Ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer (HYPO-RT-PC): 10-year outcomes of an open-label, randomised, phase 3, non-inferiority trial

Lancet Oncol

Nilsson P, Gunnlaugsson A, Beckman L, Widmark A, Fransson P, Hoyer M, Lagerlund M, Kindblom J, Johansson B, Björnlinger K, Ginman C, Olsson M, Agrup M, Kjellén E, Zackrisson B, Tavelin B, Franzén L, Anderson H, Thellenberg Karlsson C

doi: 10.1016/S1470-2045(25)00656-4

Genitourinary Cancer

Stockholm3 Versus Prostate-specific Antigen in Prostate Cancer Screening: 9-year Outcomes Demonstrating Improved Detection of Aggressive Cancers and Reduced Overdiagnosis from the STHLM3 Trial

Eur Urol

Vigneswaran HT, Palsdottir T, Micoli C, Tilki D, Lin D, Cooperberg M, Eggener S, Falagario UG, Möller A, Aly M, Akre O, Wiklund P, Egevad L, Grönberg H, Nordström T, Eklund M

doi: 10.1016/j.eururo.2025.10.001

Lung, Respiratory and Thoracic Cancer

European experience on oncological outcomes of patients with early-stage non-small cell lung cancer and any prior cancer following lobectomy or segmentectomy

Lung Cancer

Lula LJ, Costa R, Huang L, Rushwan A, Domjan M, Franssen AJPM, Weedle R, Trabalza Marinucci B, Barreda CF, Jasovic C, Whooley J, Matache RS, Özgür EG, Ryan R, Young V, Tahiri M, Fernandes P, Rendina EA, Bekiroglu N, de Loos ER, Jimenez M, Savu C, Bolca C, Stupnik T, Fitzmaurice GJ, D'Andrilli A, Brunelli A, Petersen RH

doi: 10.1016/j.lungcan.2026.109410

Genitourinary Cancer

Focal laser ablation in prostate cancer: a systematic review and meta-analysis

BJU Int

Bushati Y, Guo AA, Muston BT, Bushati A, Sathianathen N, Kam J, Teoh J, Khadra M, Thangasamy I

doi: 10.1111/bju.70064

Further Publications

Virtual Sustained Tobacco Treatment for Patients With Cancer: A Randomized Controlled Trial (ECOG-ACRIN: EAQ171CD) Within the National Cancer Institute Community Oncology Research Program

J Clin Oncol

Park ER, Sicks JD, Goshe BM, Gareen IF, Herman BA, Taurone A, Bittig S, Walter AW, Regan S, Rosen R, Durieux N, Rasmussen AW, Levy DE, Nicolosi G, Muzikansky A, Thompson MA, Lui M, Malloy L, Gonzalez I, Finkelstein-Fox L, Munson ND, Greenwade MM, King DM, Jenigiri B, Burnette BL, Throckmorton AD, Tingen MS, Carlos RC, Wagner LI, Ostroff JS

doi: 10.1200/JCO-25-02267

Genitourinary Cancer

Impact of Intraprostatic Simultaneous Integrated Boost on Long-Term Outcomes in Unfavorable Intermediate-Risk Prostate Cancer Treated With Dose-Escalated Radiotherapy and Short-Term Androgen Deprivation Therapy

Prostate

Onal C, Elmali A, Demirhan B, Senturk E, Erpolat P, Guler OC

doi: 10.1002/pros.70167

Related content

Long-term oncological outcomes from a prospective cohort of patients with localised prostate cancer

Oncological Outcomes Following Focal HIFU and Cryotherapy for Treatment of Nonmetastatic Prostate Cancer in the United Kingdom: An Updated Analysis of 3477 Patients from the Prospective HEAT and ICE Registries

Focal radiation therapies for localized prostate cancer: a systematic review of clinical evidence and outcomes

Ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer (HYPO-RT-PC): 10-year outcomes of an open-label, randomised, phase 3, non-inferiority trial

Stockholm3 Versus Prostate-specific Antigen in Prostate Cancer Screening: 9-year Outcomes Demonstrating Improved Detection of Aggressive Cancers and Reduced Overdiagnosis from the STHLM3 Trial

European experience on oncological outcomes of patients with early-stage non-small cell lung cancer and any prior cancer following lobectomy or segmentectomy

Focal laser ablation in prostate cancer: a systematic review and meta-analysis

Virtual Sustained Tobacco Treatment for Patients With Cancer: A Randomized Controlled Trial (ECOG-ACRIN: EAQ171CD) Within the National Cancer Institute Community Oncology Research Program

Impact of Intraprostatic Simultaneous Integrated Boost on Long-Term Outcomes in Unfavorable Intermediate-Risk Prostate Cancer Treated With Dose-Escalated Radiotherapy and Short-Term Androgen Deprivation Therapy